Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction

Jpn Circ J. 1997 May;61(5):455-8. doi: 10.1253/jcj.61.455.

Abstract

Adjunctive intracoronary administration of nicorandil, an ATP-sensitive potassium channel opener, after successful coronary revascularization was performed in a 54-year-old patient with acute myocardial infarction. The 'no-reflow' phenomenon disappeared after nicorandil administration and significant functional recovery of the infarcted myocardium was achieved. This suggests that nicorandil could eliminate the 'no-reflow' phenomenon after successful coronary revascularization.

Publication types

  • Case Reports

MeSH terms

  • Coronary Circulation / drug effects*
  • Coronary Vessels
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / physiopathology
  • Myocardial Reperfusion
  • Niacinamide / administration & dosage
  • Niacinamide / analogs & derivatives*
  • Niacinamide / therapeutic use
  • Nicorandil
  • Potassium Channels / agonists*
  • Thrombolytic Therapy
  • Ultrasonography

Substances

  • Potassium Channels
  • Niacinamide
  • Nicorandil